PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2022.04222023292320-331Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectivesShang-Chin Huang, Chun-Jen Liuhttp://e-cmh.org/upload/pdf/cmh-2022-0422.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0422, http://e-cmh.org/upload/pdf/cmh-2022-0422.pdf
Journal of Hepatology10.1016/j.jhep.2021.02.0132021751236-238Dynamics of liver stiffness in chronic hepatitis B patients with concurrent metabolic-associated fatty liver diseaseDanny Con, Daniel Clayton-Chubb, John Lubel, Rohit Sawhney, Stephen Bloomhttps://api.elsevier.com/content/article/PII:S0168827821001136?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827821001136?httpAccept=text/plain
Journal of the Formosan Medical Association10.1016/j.jfma.2022.07.0132022121112148-2151Metabolic dysfunction-associated fatty liver disease and chronic hepatitis BShang-Chin Huang, Jia-Horng Kaohttps://api.elsevier.com/content/article/PII:S0929664622002868?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0929664622002868?httpAccept=text/plain
10.21203/rs.3.rs-494412/v32021Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver diseaseA lum Hanhttps://www.researchsquare.com/article/rs-494412/v3, https://www.researchsquare.com/article/rs-494412/v3.html
10.21203/rs.3.rs-494412/v22021Validation of Fatty Liver Index as a Marker for Metabolic Dysfunction-Associated Fatty Liver DiseaseA lum Han, Youngjon Kimhttps://www.researchsquare.com/article/rs-494412/v2, https://www.researchsquare.com/article/rs-494412/v2.html
10.21203/rs.3.rs-494412/v12021Validation of Fatty Liver Index as a Marker for Metabolic Dysfunction-associated Fatty Liver DiseaseA lum Han, Youngjon Kimhttps://www.researchsquare.com/article/rs-494412/v1, https://www.researchsquare.com/article/rs-494412/v1.html
Clinical Liver Disease10.1002/cld.12502022205157-161The Shift from nonalcoholic fatty liver disease to metabolic dysfunction–associated fatty liver diseaseRochelle Wong, Brett E. Fortunehttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.1250, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cld.1250, https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.1250
eBioMedicine10.1016/j.ebiom.2021.103584202172103584What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD)Fernando Brilhttps://api.elsevier.com/content/article/PII:S2352396421003777?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2352396421003777?httpAccept=text/plain
Alimentary Pharmacology & Therapeutics10.1111/apt.172702022572270-271Editorial: chronic hepatitis C with metabolic dysfunction‐associated fatty liver disease — a model for adoption of Sustainable Development Goal 3Oyekoya Ayonrinde, Richard Goodhearthttps://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17270, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/apt.17270, https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17270
Nephrology Dialysis Transplantation10.1093/ndt/gfac1882022383700-711Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver diseaseMarenao Tanaka, Kazuma Mori, Satoko Takahashi, Yukimura Higashiura, Hirofumi Ohnishi, Nagisa Hanawa, Masato Furuhashihttps://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfac188/44477535/gfac188.pdf, https://academic.oup.com/ndt/article-pdf/38/3/700/49352574/gfac188.pdf, https://academic.oup.com/ndt/article-pdf/38/3/700/49352574/gfac188.pdf